207 related articles for article (PubMed ID: 33357196)
21. Clinical features of silent corticotroph adenomas.
Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
[TBL] [Abstract][Full Text] [Related]
22. A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors.
Goyal-Honavar A; Sarkar S; Asha HS; Kapoor N; Balakrishnan R; Vanjare H; Chacko G; Chacko AG
Acta Neurochir (Wien); 2021 Nov; 163(11):3143-3154. PubMed ID: 34181087
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
[TBL] [Abstract][Full Text] [Related]
24. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
25. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.
Iino K; Oki Y; Matsushita F; Yamashita M; Hayashi C; Miura K; Nishizawa S; Nakamura H
Pituitary; 2007; 10(1):35-45. PubMed ID: 17410413
[TBL] [Abstract][Full Text] [Related]
27. Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience.
Erickson D; Scheithauer B; Atkinson J; Horvath E; Kovacs K; Lloyd RV; Young WF
Clin Endocrinol (Oxf); 2009 Jul; 71(1):92-9. PubMed ID: 19170710
[TBL] [Abstract][Full Text] [Related]
28. Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.
Rui W; Qiao N; Wu Y; Zhang Y; Aili A; Zhang Z; Ye H; Wang Y; Zhao Y; Yao Z
Eur Radiol; 2022 Mar; 32(3):1570-1578. PubMed ID: 34837512
[TBL] [Abstract][Full Text] [Related]
29. Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.
Lee MH; Hur KY; Hong SD; Seol HJ; Choi JW; Lee JI; Nam DH; Kong DS
J Neurooncol; 2021 Jun; 153(2):343-350. PubMed ID: 34002303
[TBL] [Abstract][Full Text] [Related]
30. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
Rak B; Maksymowicz M; Pękul M; Zieliński G
Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
[TBL] [Abstract][Full Text] [Related]
31. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
32. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
34. Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas.
Cheres AF; ElAsmar N; Rajpal A; Selman WR; Arafah BM
Pituitary; 2017 Aug; 20(4):471-476. PubMed ID: 28528397
[TBL] [Abstract][Full Text] [Related]
35. Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas.
Cazabat L; Dupuy M; Boulin A; Bernier M; Baussart B; Foubert L; Raffin-Sanson ML; Caron P; Bertherat J; Gaillard S
Clin Endocrinol (Oxf); 2014 Oct; 81(4):566-72. PubMed ID: 24601912
[TBL] [Abstract][Full Text] [Related]
36. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
37. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence.
Strickland BA; Shahrestani S; Briggs RG; Jackanich A; Tavakol S; Hurth K; Shiroishi MS; Liu CJ; Carmichael JD; Weiss M; Zada G
J Neurosurg; 2021 May; 135(6):1706-1713. PubMed ID: 33962375
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of clinically silent corticotroph macroadenomas.
Guttenberg KB; Mayson SE; Sawan C; Kharlip J; Lee JY; Martinez-Lage M; Loevner LA; Ewanichak J; Grady MS; Snyder PJ
Clin Endocrinol (Oxf); 2016 Dec; 85(6):874-880. PubMed ID: 27346850
[TBL] [Abstract][Full Text] [Related]
39. Silent pituitary adenoma and metabolic disorders: obesity, abnormal glucose tolerance, hypertension and dyslipidemia.
Baba N; Kameda H; Nakamura A; Yong Cho K; Nomoto H; Mitsuhashi T; Miyoshi H; Atsumi T
Endocr J; 2021 Feb; 68(2):195-200. PubMed ID: 33028757
[TBL] [Abstract][Full Text] [Related]
40. Subclinical hyperfunctioning pituitary adenomas: the silent tumors.
Cooper O; Melmed S
Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):447-60. PubMed ID: 22863387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
